Piermont Capital Management’s Karyopharm Therapeutics KPTI Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2017 Q1	–	Sell	-3,405	Closed	-$480K	–	262
2016 Q4	$480K	Sell	3,405 -67	-2%	-$9.45K	0.11%	230
2016 Q3	$507K	Buy	+3,472	New	+$507K	0.12%	234